A randomized phase 2 maintenance strategy with cabozantinib 60 mg daily for up to 2 years failed to improve 4-month PFS versus placebo in high-grade uterine sarcomas. Median PFS was identical at 3.7 ...

Raise money for a good cause and get a workout at the same time. Sarcoma survivor Jerry Glisch joins FOX6 WakeUp with more on how you can get involved in this year's Race to Cure Sarcoma.

Specialized sarcoma centers enhance coordinated care for young adults, although travel and financial barriers persist, Dr. Vinayak Venkataraman stated. Specialized, multidisciplinary care at ...

New research from Dartmouth Health and Dartmouth Cancer Center reveals a glowing molecule designed to highlight soft-tissue sarcomas during surgery, paving the way for more precise tumor removal and ...

A DR5-mediated apoptotic strategy combined with irinotecan/temozolomide achieved a 64.5% ORR and 87.1% DCR in ...

HONOLULU (KHON2) — July is National Sarcoma Awareness Month, a time to recognize the signs of this rare type of cancer that affects about 17,000 people in the U.S. every year. Sarcoma is a cancer that ...

Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer Safety and Tolerability of ...

Symptoms that mimic fibroids make diagnosing uterine sarcoma a rare and confounding cancer. In 2014, Dionne Shepperson, then 40 and pregnant, began feeling weak and faint. Because she had in the past ...

Ewing sarcoma is a malignant type of bone tumor, meaning it is a form of cancer that spreads. According to a 2024 review, Ewing sarcoma is the second most common primary cancerous bone tumor. It ...

Immune Checkpoint Inhibitors in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor–Resistant Chemotherapy-Naïve Advanced Non–Small Cell Lung Cancer: A Meta-Analysis Based on Eight Randomized ...

Synovial sarcoma, a rare cancer, thrives on glutamine. Blocking its nutrient supply with the drug V9302 stops tumor growth, offering a new way to treat the disease.

A new Curtin University study has found that people diagnosed with sarcoma—a cancer disproportionately affecting teenagers and young adults—are being left without the resources they urgently need.